Clinical trials
Psoriatic Arthritis (PsA) clinical trials
Below are recruiting psoriatic arthritis (psa) clinical trials, each written for real people, not researchers. We’re tracking 62 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02530268Enrolling by invitation
Registry for psoriatic arthritis and spine arthritis patients starting treatment
This is a patient registry that tracks people with psoriatic arthritis or spine inflammatory arthritis when they start a specific new treatment. It helps researchers learn about real-world outcomes and safety as patients receive care over time.
Ages 18 years+ - NCT07443956Recruiting
Biologic and anti-obesity drug combo for psoriatic arthritis
This study tests whether adding a weight-loss medication (tirzepatide) to a biologic (ixekizumab) helps people with psoriatic arthritis and overweight or obesity. You will need to have biopsies of joint tissue and fat to see how the treatment affects inflammation.
Birmingham, EnglandAges 18–75 - NCT07455578RecruitingPhase 1
Study of S-4321 for people with autoimmune or immune diseases
This trial tests a new medicine, S-4321, for people with various autoimmune conditions like rheumatoid arthritis, psoriasis, eczema, or lupus. It aims to see if the drug is safe and can help control the overactive immune system.
Charlestown, New South WalesAges 18–75 - NCT07486843RecruitingPhase 4
Preventing joint damage in early psoriatic arthritis
This trial tests if a treatment can prevent joint damage in people recently diagnosed with psoriatic arthritis. It compares a standard medication (methotrexate) with or without a newer biologic drug (adalimumab) to see which is better at stopping the disease from causing lasting harm.
Hong KongAges 18 years+ - NCT07536529Recruiting
Oxidative Stress in Autoimmune Joint Diseases
This study looks at a type of cellular damage called oxidative stress in people with autoimmune joint diseases like rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. Researchers want to understand how this damage relates to your disease and may help develop better treatments.
Larissa, ThessalyAges 18 years+ - NCT07611747RecruitingPhase 4
Ultrasound Screening to Prevent Heart Disease in Rheumatic Patients
This study tests whether using ultrasound to look at arteries in the neck can help prevent heart attacks and strokes in people with inflammatory joint diseases like rheumatoid arthritis or lupus. Researchers will use the results to guide treatment decisions.
Alicante, AlicanteAges 50 years+ - NCT07223138Enrolling by invitationPhase 3
Long-term safety study of sonelokimab for psoriatic arthritis
This study is for people who have already been in a previous trial of sonelokimab for psoriatic arthritis and want to continue treatment. It checks how safe and effective the medicine is over a longer time.
Avondale, ArizonaAges 18 years+ - NCT07150000Recruiting
Rheumatic disease research study for patients and healthy volunteers
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
Bonn, North Rhine-WestphaliaAges 18 years+ - NCT07532226Recruiting
Tracking how long patients stay on guselkumab for psoriatic arthritis
This study follows people with psoriatic arthritis (joint pain and swelling linked to psoriasis) who are starting a newer medication called guselkumab. Researchers want to learn how long patients continue taking this medicine and how well it works for them.
LilleAges 18 years+ - NCT03248284Recruiting
Study of inflammation in Achilles tendons in psoriatic arthritis
This trial studies people with psoriatic arthritis who have painful Achilles tendon insertion with signs of inflammation on ultrasound. It may help researchers better understand what drives tendon inflammation and how it can be treated.
OdenseAges 18–70 - NCT04804553RecruitingPhase 3
Apremilast for children with active juvenile psoriatic arthritis
This Phase 3 trial tests apremilast to treat active juvenile psoriatic arthritis (joint inflammation) in children and teens. You may be able to join if your child’s condition is active despite prior treatments or if they couldn’t tolerate them.
BregenzAges 5–17 - NCT05652608Recruiting
Psoriatic arthritis wellness survey for adults in the US
This study is looking at how people living with psoriatic arthritis (PsA) are doing through a wellness survey. If you live in the US or Puerto Rico, have PsA, and are taking prescribed PsA medicine, you may be able to share your experience through online questionnaires.
Upper Nyack, New YorkAges 19 years+ - NCT06382051Recruiting
Improving Psoriatic Arthritis Screening in Psoriasis
This study tests a new way to screen for psoriatic arthritis (a type of joint inflammation) in people with psoriasis. It looks at a tool called PEST and aims to improve early detection.
Calgary, AlbertaAges 18 years+ - NCT07486960RecruitingPhase 2
Study of Tulisokibart for Psoriatic Arthritis
This trial tests a new drug called tulisokibart for people with psoriatic arthritis (PsA), a condition that causes joint pain and skin plaques. It may help if you have not tried certain biologic medications or if they did not work well.
Sun City, ArizonaAges 18–80 - NCT04190758Enrolling by invitation
Early arthritis study for RA, psoriatic arthritis, and psoriasis
This study looks at people with early arthritis related to rheumatoid arthritis, psoriatic arthritis, or psoriasis. Researchers want to understand how these early conditions behave and may help guide better treatment decisions.
GothenburgAges 18–80 - NCT07166315Recruiting
Comparing new treatments for arthritis of the spine or joints
This study looks at how well different newer medications work for people with axial spondyloarthritis or psoriatic arthritis. It focuses on those just starting treatment with bimekizumab, risankizumab, guselkumab, upadacitinib, or a TNF inhibitor.
Bath, SomersetAges 18 years+ - NCT07087912RecruitingPhase 4
Dengue vaccine safety in people with autoimmune rheumatic diseases
This study tests the safety and immune response of a dengue vaccine in people aged 12–59 with stable autoimmune rheumatic diseases (like rheumatoid arthritis or lupus) who are on low-dose or no immune-suppressing medications. It also includes healthy volunteers for comparison.
São Paulo, São PauloAges 12–59 - NCT06299917Recruiting
Work rehabilitation for inflammatory arthritis
This study offers a work-focused rehabilitation program for people with inflammatory arthritis who are worried about keeping their job or staying in school. The program aims to help you stay employed or continue your education by providing tailored support.
SønderborgAges 18–65 - NCT06671483RecruitingPhase 3
Zasocitinib for psoriatic arthritis without prior biologic use
This trial tests an oral medication called zasocitinib for adults with psoriatic arthritis who have not tried biologic medicines before. It aims to see if the drug can improve joint pain, swelling, and skin symptoms.
Chandler, ArizonaAges 18 years+ - NCT06641089RecruitingPhase 3
Sonelokimab for psoriatic arthritis after TNF inhibitor failure
This study tests an investigational drug called sonelokimab for people with active psoriatic arthritis who have already tried a TNF-alpha inhibitor (like adalimumab) and it didn't work well enough. The goal is to see if sonelokimab can reduce joint pain and swelling and improve skin symptoms.
Avondale, ArizonaAges 18 years+ - NCT06730334Recruiting
Psoriatic arthritis study using ultrasound to track activity
This study uses power Doppler ultrasound to classify and measure how active your psoriatic arthritis is. It may help doctors better understand and treat your condition.
Nanjing, JiangsuAges 18 years+ - NCT06671496RecruitingPhase 3
Zasocitinib for psoriatic arthritis in adults
This study tests an oral medicine called zasocitinib for people with psoriatic arthritis who have not had enough relief from other treatments. It may help reduce joint pain and skin symptoms.
Mesa, ArizonaAges 18 years+ - NCT06583980Recruiting
Study for people with arthritis who want better symptom control
This trial is testing a new approach to help people with arthritis who are not satisfied with their symptom control. It may be a good fit if you have rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis and are still struggling with fatigue, pain, or how the disease affects your daily life.
FrederiksbergAges 18–100 - NCT05039216Recruiting
Biobank for inflammatory arthritis and osteoporosis
This study collects and stores health information and samples for people with long-term inflammatory arthritis (like rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis) or with osteoporosis. It helps researchers understand these conditions and may lead to better future treatments.
ToulouseAges 18–99
Hear when a new Psoriatic Arthritis (PsA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for psoriatic arthritis (psa)?
- Yes. Clin2 currently lists 62 recruiting psoriatic arthritis (psa) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a psoriatic arthritis (psa) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a psoriatic arthritis (psa) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.